Mo Elsayed, MD

Metformin: A diabetes drug with FASCINATING anti-aging and anti-cancer properties. Data shows it can improve response to cancer treatments. Our new study suggests that it can enhance tumor response to Y-90 radiotherapy in HCC. Manuscript here: pubmed.ncbi.nlm.nih.gov/34312687/

Interventional radiology for dermatologic conditions? 🤔@JVIRmedia @SIR_ECS @sir

New @ScienceMagazine Discovery of a circuit that connects stress and skin inflammation science.org/doi/10.1126/sc… science.org/doi/10.1126/sc…

Prostatic Artery Embolization vs TURP: "All outcomes, including IPSS, QOL, peak flow, and postvoid residual volume (PVR), were equivalent at 12 and 24 months. TURP --> higher rates of bladder catheterization and hospitalization. Major complications were encountered only in the TURP group." jvir.org/article/S1051-… #iRad

1/4 Exciting to share that our latest research, "Hyperthermia-targeted rectal delivery of thermosensitive liposomal doxorubicin via intra-arterial and intravenous administration," has been published in Frontiers in Pharmacology >> frontiersin.org/journals/pharm…

Over 300 cases a year shared between heart transplant, lung transplant, and Heartmate 3 LVADs… here’s to another one ✈️ 🫀🫁

@sdamico Fantastic read. Hopefully the "Electric Stack" concept catches on so we can better focus our efforts! Thank you @sdamico @packyM

Huge post on WHY we're seeing everything that can possibly electrify, electrify -- there's a new technology stack, and it's eating the world: batteries, power electronics, electromagnetics, and compute. TLDR: It's better and CAN BE CONTROLLED BY SOFTWARE. 🧵

Fascinating approach for an all too common problem. Amazing developments happening in NeuroIR!

There's been amazing progress against liver cancer over the last 60 years (Specifically, hepatocellular carcinoma treated with surgery) What's driven the progress? Earlier detection, safer and better operations, better biomarkers, and better treatment of recurrence

First United States⁩ ⁦@SiemensHealth⁩ Biograph ONE PET/MRI. Ready for installation in the Center for Clinical Imaging Research ⁦@WashUMedMIR⁩ (signed for in 2018 - well worth the wait!) ⁦

1/ Minimally invasive thoracic interventions are more than salvage therapy. They're tools for curation, palliation, & consolidation. Let's walk through the key approaches 🧵 @RadioGraphics @cookyscan1 @teachplaygrub @DrAnnaSophia @MSKCancerCenter @costishere

@Neil_Iyengar @WinshipAtEmory Welcome to GA! Congratulations 👏🏼

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

0/ Lung cryoablation (LCA) is a powerful yet underutilized tool in thoracic oncology. Our international team reviews patient selection, technique, complications, and imaging outcomes to master LCA in practice 🧵👇 @RadioGraphics @RadG_Editor @cookyscan1 @teachplaygrub #RGphx

@t_intheleadcoat @farkomd @JayMathewsMD @kmadass @LessneVIR @CraigMWalkerMD @SDhandMD @keithppereira @limbsalvagedr @roblookstein @saherssabri @docTPlive @HadyLichaaMD @laronecampbell @IR_Doctor @IRKhalsa @linemonkeymd @baijazvascular @_backtable @DrJayMohan @jmills1955 Well done! What was your end point for thrombin injection while the balloon was up?

Not sure if this qualifies for a wide neck #PSA but balloon assisted thrombin injection can save a 🔪 When do you consider it? @farkomd @JayMathewsMD @kmadass @LessneVIR @CraigMWalkerMD @SDhandMD @keithppereira @limbsalvagedr @roblookstein @saherssabri @docTPlive

Important recent @AnnSurgOncol study from @WashUSurgery looking retrospectively at long-term outcomes of near-complete responses who undergo #WatchAndWait for rectal cancer. Almost all patients received SCRT followed by consolidation chemo-->48% cCR, 28% near-complete (NCR), and 24% incomplete The NCRs (n=61) had a median f/u of 27 months: 6.6% developed distant metastasis and 41% developed local regrowth. The next part is important! Please keep reading! 64% of NCRs evolved into cCRs within 3-6 months. Of those, only 15% (6/39) developed local regrowth. 36% of NCRs continued to be NCRs (ulcers, nodularities, abnormal MRIs), and 86% of these (19/22) developed local regrowth. 21 patients underwent salvage surgery with 95%=R0. Unfortunately, 4/21 (19%) developed local recurrence after surgery. What does this mean to me? Near-complete responses can evolve into cCRs in 3-6 months, and have excellent outcomes with watch-and-wait...they just needed a little more time. However, if the irregularity remains after 3-6 months, I'm putting that rectum in a bucket. pubmed.ncbi.nlm.nih.gov/39982548/

Online First: Results from the COLLISION trial: Thermal #ablation versus #surgical resection of small-size #ColorectalLiverMetastases: an international, randomised, controlled, phase 3 non-inferiority trial thelancet.com/journals/lanon…

@AshleyAaroe @abkhan_md @NeuroOnc @JHUAlumniAssoc @MDAndersonNews @DrJeffWeinberg @Lymphoma_Doc So cool! Congratulations @ab

Back from hiatus to shout out @abkhan_md for his great presentation at @NeuroOnc #SNO2024 on CNS lymphoma. Lots of non-lymphomatous pathology to keep an eye out for too. Also bonkers how small the @JHUAlumniAssoc world is especially in medicine, especially in neuro fields!

@maxwellcoopermd @NorthwesternIR @NURadiology Well deserved huge congrats!

Excited to share that I matched at Northwestern for IR fellowship!! @NorthwesternIR @NURadiology

With a truly commendable methodology the Dutch COLLISION trial shows non-inferiority of thermal ablation to resection for small (<3cm) colorectal cancer liver metastases #ASCO24 #crcsm #231641" target="_blank" rel="nofollow noopener">meetings.asco.org/2024-asco-annu…

First results of the CM8HW are out! Nivo/ipi vs chemo in 1st line dMMR mCRC. We knew it would be positive, but wow 🤯 HR 0.21 for PFS and + across all subgroups. No crossing of the curves! Toxicity very manageable (don’t be scared of low dose ipi1).

Amazing work by a rising star! @EshaniChoksi @NimaKokabiMD @SIRRFS